Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone in Systemic Right Ventricle
NCT00703352Phase 4Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Jul 2008
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of eplerenone in transposition of the great arteries (TGA), sponsored by Vall d'Hebron Research Institute. Started Jul 2008; status: completed.
02
Drugs
eplerenone
03
Conditions
transposition of the great arteries (TGA)
Beyond the preview
Go deeper on NCT00703352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00703352.